A business in context

BNTC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-05 · 0001193125-26-413177 · Items 7.01,9.01

  2. 8-K · Current report

    Report date 2026-09-29 · 0001193125-26-409052 · Items 4.01

  3. 8-K · Current report

    Report date 2026-09-18 · 0001193125-26-401110 · Items 4.01,9.01

  4. 10-K · Annual report

    Report date 2026-06-30 · 0001193125-26-390570

  5. 8-K · Current report

    Report date 2026-09-14 · 0001193125-26-390539 · Items 2.02,9.01

  6. 4 · Ownership change

    Report date 2026-06-29 · 0001193125-26-290586

  7. 8-K · Current report

    Report date 2026-05-22 · 0001193125-26-248289 · Items 5.02

  8. 4 · Ownership change

    Report date 2026-05-26 · 0001193125-26-245918

  9. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-222885

  10. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-222879 · Items 2.02,9.01

  11. 10-K/A · Annual report

    Report date 2025-06-30 · 0001193125-26-117604

  12. 8-K · Current report

    Report date 2026-02-12 · 0001193125-26-047742 · Items 2.02,9.01

  13. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001193125-26-047737

  14. 4 · Ownership change

    Report date 2026-01-22 · 0001012975-26-000082

  15. 4 · Ownership change

    Report date 2025-12-23 · 0000899140-25-001479

  16. 4 · Ownership change

    Report date 2025-12-18 · 0000899140-25-001459

  17. 4 · Ownership change

    Report date 2025-12-01 · 0001012975-25-000851

  18. 4 · Ownership change

    Report date 2025-12-01 · 0001012975-25-000850

  19. 4 · Ownership change

    Report date 2025-12-01 · 0001012975-25-000849

  20. 8-K · Current report

    Report date 2025-12-01 · 0001193125-25-305475 · Items 5.07

  21. 8-K · Current report

    Report date 2025-11-14 · 0001193125-25-283351 · Items 2.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-283274

  23. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-270490 · Items 1.01,8.01,9.01

  24. 8-K · Current report

    Report date 2025-11-02 · 0001193125-25-261665 · Items 5.02,7.01,8.01,9.01

  25. DEF 14A · Proxy statement

    Report date 2025-12-01 · 0001193125-25-239131

  26. 8-K · Current report

    Report date 2025-09-22 · 0001193125-25-211462 · Items 2.02,9.01

  27. 10-K · Annual report

    Report date 2025-06-30 · 0001193125-25-211361

  28. 8-K · Current report

    Report date 2025-09-10 · 0000950170-25-114530 · Items 4.02

  29. 8-K · Current report

    Report date 2025-07-09 · 0001193125-25-157095 · Items 7.01,9.01

  30. 8-K · Current report

    Report date 2025-05-14 · 0001193125-25-119402 · Items 2.02,9.01

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001193125-25-119383

  32. 8-K · Current report

    Report date 2025-03-26 · 0001193125-25-067232 · Items 8.01

  33. 8-K · Current report

    Report date 2025-03-26 · 0001193125-25-065613 · Items 1.01,9.01

  34. 8-K · Current report

    Report date 2025-03-25 · 0001193125-25-063235 · Items 1.01,8.01,9.01

  35. 8-K · Current report

    Report date 2025-03-20 · 0001193125-25-059398 · Items 8.01

  36. 8-K · Current report

    Report date 2025-03-19 · 0001193125-25-057153 · Items 7.01,9.01

  37. 8-K · Current report

    Report date 2025-02-14 · 0001193125-25-026659 · Items 2.02,9.01

  38. 10-Q · Quarterly report

    Report date 2024-12-31 · 0001193125-25-026631

  39. 8-K/A · Current report

    Report date 2024-12-27 · 0001193125-24-287065 · Items 5.02

  40. 8-K · Current report

    Report date 2024-12-09 · 0001193125-24-278529 · Items 5.02

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001808898Benitec Biopharma Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-06-30$0$0
    2023-06-30$75.0K$84.3K
    2022-06-30$73.0K$87.2K
    2021-06-30$59.0K$75.5K
    2020-06-30$97.0K$127.1K
    2019-06-30$11.55M$15.37M

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗